{
  "@context": {
    "@vocab": "http://schema.org/",
    "rdau": "http://rdaregistry.info/Elements/u/",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "skos:prefLabel": {
      "@container": "@language"
    }
  },
  "@graph": [
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00050168600",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p21824"
      },
      "name": "Novel prodrug structures for improved drug delivery"
    },
    {
      "@id": "http://www.yso.fi/onto/yso/p21824",
      "name": "aihiolääkkeet"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00576662500",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p21824"
      },
      "name": [
        "Blood-brain barrier transporters in CNS drug delivery : design and biological evaluation of LAT1 and GluT1 : targeted prodrugs",
        "Blood-brain barrier transporters in CNS drug delivery : design and biological evaluation of LAT1 and GluT1 -targeted prodrugs",
        "Blood-brain barrier transporters in CNS drug delivery :"
      ]
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00731797400",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p21824"
      },
      "name": [
        "Nucleotides as antiviral compounds : on the feasibility of an esterase-dependent prodrug strategy for 2-5A",
        "Nucleotides as antiviral compounds :"
      ]
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00687728000",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p21824"
      },
      "name": "New bioactive secondary metabolites from cyanobacteria"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00912125100",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p21824"
      },
      "name": [
        "Prodrug strategies of antiviral nucleotides : studies on enzymatically and thermally removable phosphate protecting groups",
        "Studies on enzymatically and thermally removable phosphate protecting groups",
        "Prodrug strategies of antiviral nucleotides :"
      ]
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00641013500",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p21824"
      },
      "name": "Strategies to enhance drug delivery to the brain : biological studies with large amino acid transporter 1 (LAT1) in prodrug design"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00527575800",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p21824"
      },
      "name": "Novel prodrug structures for improved and targeted drug delivery : design, synthesis and in Vitro/in Vivo evaluation"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00621006600",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p21824"
      },
      "name": "Cytochrome P450-selective prodrugs and inhibitors"
    }
  ]
}